Pioneer Research Solutions, Inc.

05/30/2026

*🚨 High Blood Pressure Study*

Is your BP still high even while taking 3 or more BP medicines?

You may qualify for a clinical research study for difficult-to-control / resistant high blood pressure.

Qualified participants may receive no-cost study-related exams, BP monitoring, and possible compensation for time/travel.

Contact:
Saleem Sajwani
713-903-9674
[email protected]

04/14/2026

Do you have IBS with diarrhea or mixed bowel habits?
You may qualify for a clinical research study.
We are looking for adults 18 to 80 years old who have been diagnosed with:
IBS-D — Irritable Bowel Syndrome with Diarrhea
IBS-M — Irritable Bowel Syndrome with Mixed Bowel Habits
This study is evaluating camlipixant, an investigational medication sponsored by GSK. To qualify, participants may need to meet study screening criteria, including Rome IV criteria, and have moderate to severe IBS symptoms.
If you or someone you know experiences frequent diarrhea, urgent bowel movements, abdominal discomfort, bloating, or mixed bowel habits, this study ma


















be a good fit. IBS-C and IBS-U are not the target diagnoses for this trial.
Interested? Contact us to learn more and see if you may qualify.
Pioneer Research Solutions Inc.
10700 Stancliff Rd
Houston, TX 77099
Call or Text: 713-903-9674
Email: [email protected]

04/10/2026

DO YOU USE AN INHALER?
Have you been diagnosed with asthma?
Be part of our Asthma Research Study
Learn more about asthma and breathing in a real-world research study.
*Free asthma study-related tests may include:*
*FeNO breath test*
*Spirometry (lung function test)*
*Blood work*
Asthma questionnaires
No experimental medication
Regular asthma care continues
*Compensation: Get $138*
Pioneer Research Solutions Inc.
10700 Stancliff Rd, Houston, TX 77099
Call or Text: 713-903-9674
[email protected]

04/09/2026

Thrilled to share this recognition for the Pioneer Research Solutions Inc. Study Team as Top Agents for the ENLIGHTEN-Fibrosis program.
The ENLIGHTEN-Fibrosis Study is a Phase 3 research study for adults with MASH (fatty liver with inflammation) and liver fibrosis F2–F3. The study is evaluating pegozafermin, an investigational treatment that may help improve liver scarring and overall liver health. Qualified participants may undergo screening tests to determine eligibility.
At Pioneer Research Solutions, we remain committed to advancing clinical research, expanding access to innovative studies, and helping connect patients with potential new treatment options.
Grateful to our dedicated team for their hard work, commitment, and passion for patient care and research excellence.

03/20/2026

Eid Mubarak from Pioneer Research Solutions Inc. 🌙
“Allah intends ease for you, not hardship.” — Quran 2:185 �
Quran.com
Today is a reminder of gratitude, faith, service, and hope.
May this Eid bring peace to every heart, blessings to every home, and success to every good intention.

Keep faith. Spread kindness. Serve humanity. Shine with purpose.
— Saleem Sajwani
Pioneer Research Solutions Inc.
713-903-9674

03/09/2026

02/18/2026

🌙✨ Ramadan Mubarak from Pioneer Research Solutions Inc. ✨🌙
يَا أَيُّهَا الَّذِينَ آمَنُوا كُتِبَ عَلَيْكُمُ الصِّيَامُ كَمَا كُتِبَ عَلَى الَّذِينَ مِن قَبْلِكُمْ لَعَلَّكُمْ تَتَّقُونَ
“O you who have believed, fasting has been prescribed upon you as it was prescribed upon those before you that you may become righteous.” (Qur’an 2:183)
This blessed month reminds us of patience, compassion, discipline, and gratitude.
At Pioneer Research Solutions Inc, we are committed to serving our community with care, integrity, and excellence.
May this Ramadan bring peace to your heart, health to your body, and blessings to your home. 🤲✨

01/23/2026

🎯 Clinical Trial Opportunity: IBS-C in Children
We’re looking for children ages 6–18 years with IBS-C (Irritable Bowel Syndrome with Constipation) to join a 4-week research study!
What is this study about?
✅ Testing different doses of a new medication for IBS-C
✅ Relieve constipation and improve bowel habits safely
Who can join?
✔️ Children 6 to 18 years old
✔️ Diagnosed with IBS-C (constipation-predominant)
✔️ Able to follow study instructions and diary entries
Who cannot join?
❌ Children with serious gastrointestinal conditions other than IBS-C
❌ Children with allergies to study medication
❌ Children who cannot comply with study visits or procedures
What will happen if my child joins?
✅ Receive study medication at different doses
✅ Parents track bowel habits and symptoms in a diary
✅ Regular clinic visits and safety checks
✅ Doctors closely monitor health and side effects
Benefits of Joining
⭐ Access to a potentially helpful new medication
⭐ Contribute to medical research to help other children
⭐ Receive close medical monitoring during the study
Contact Information
📞 Call: Saleem Sajwani – Business Development Associate
📱 Phone: (713) 903-9674
✉️ Email: [email protected]